๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ipatinga
Clinical trial register · Brazil

Clinical Trials in Ipatinga, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Brazil and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 2230 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:47 UTC
2230
Studies in scope
all four open statuses
1131
Recruiting now
open to new participants
350
Lead sponsors
across recruiting studies
Top sites
Curitiba 37 Porto Alegre 37 Sรฃo Paulo 37 Salvador 26 Natal 24
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Ipatinga

4 of 2230 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Brazil
Start
Active, closed
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
NCT05388669Advanced or Metastatic Non-small Cell Lung Cancer
Janssen Research & Development, LLC
Phase 3
418
Barretos, Belo Horizonte, Curitiba, Florianรณpolis, Ipatinga, Pelotas, Porto Alegre, Rio de Janeiro
2022-08-05
Active, closed
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
NCT04988295Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
Phase 3
776
Belo Horizonte, Curitiba, Florianรณpolis, Ipatinga, Pelotas, Porto Alegre, Rio de Janeiro, Salvador
2021-11-17
Active, closed
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)
NCT04497844Prostatic Neoplasms
Janssen Research & Development, LLC
Phase 3
696
Barretos, Belo Horizonte, Curitiba, Florianรณpolis, Fortaleza, Goiรขnia, Ipatinga, Joinville
2020-09-23
Active, closed
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
NCT03748641Castration-Resistant Prostatic Cancer
Janssen Research & Development, LLC
Phase 3
765
Barretos, Belo Horizonte, Brasรญlia, Curitiba, Fortaleza, Goiรขnia, Ijuรญ, Ipatinga
2019-01-25
Rows per page Showing 1–4 of 4
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Brazilian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 September 2026. https://priyalifescience.com/clinical-trials-brazil/city/ipatinga

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Brazil and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,230 studies in total at the last sync on 26 Sep 2026, 19:47 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 4 of those studies with a site in Ipatinga that also match the filters currently applied.

How many clinical trials are recruiting in Ipatinga?

0 of the 4 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:47 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ipatinga), 4 studies
PhaseStudiesRecruitingShare
Phase 340100%

Most active sponsors

Lead sponsors with the most studies (Ipatinga)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC40
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.